Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Medical Devices News
  • Medical equipment firm...

Medical equipment firm InstaShield, UP Govt collaborate to strengthen fight against COVID 19

Ruchika SharmaWritten by Ruchika Sharma Published On 2023-01-22T11:00:29+05:30  |  Updated On 22 Jan 2023 11:00 AM IST
Atavistik Bio, Pfizer collaborate
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

InstaShield is a plug-and-play device that kills viruses with the help of electron-transmitting technology.

Hyderabad: With the Yogi government entering into an agreement with Hyderabad-based medical equipment company InstaShield, Uttar Pradesh is set to add an effective weapon to its arsenal in the fight against the novel coronavirus (Covid-19).

InstaShield claims that its device, launched in March 2022, is 99.9 percent effective in guarding against and destroying all types of viruses including SARS-Covid. It is worth mentioning here that the company’s turnover has reached Rs 10 crore since the launch of this particular device in March 2022, an official statement said.

“The owners of the company gave a presentation of this device during the meeting with the delegation of the Yogi Government while Cabinet Minister Baby Rani Maurya expressed her liking for the innovative product of the company. CM Yogi’s team also invited the owners of the company to the Global Investors Summit to be held in Lucknow on February 10-12,” the statement added.

After meeting with Team Yogi, Instashield promoter and director CS Jadhav and Hitesh M Patel informed that they started the company in August 2017 and it is registered with MSME, Startup India, and Gem Portal. According to them, when the whole world was busy devising ways to tackle Covid-19, InstaShield invented its own to prevent the spread of the pandemic, it added.

“The device was launched in March 2022 and today the company’s turnover has reached Rs 10 crore, changing the entire picture of the company. InstaShield is a plug-and-play device that kills viruses with the help of electron-transmitting technology. InstaShield’s innovative technology works in closed spaces like homes, offices, schools, hotels, colleges, hospitals etc. without releasing any harmful radiation in the air and on surfaces and keeps the environment safe and healthy for mankind,” a statement from Instashield said.

“InstaShield device is a breakthrough device as it uses the first of its kind CCMB approved virus attenuation technology. This technology disables all types of viruses, including SARS CoV2 with 99.9 percent effectiveness. Hitesh says that a single InstaShield device is sufficient to keep an area of 5000 square feet safe from the virus. The device gets activated within 18 minutes. The InstaShield device technology is patented and supported by TSIC, and ARCI. The device is certified by CSIR-CCMB, Hyderabad as well as other labs like EMTAC, and Vimta. CSIR-CCMB is a Government Council. The company claims that the device is 100 percent safe for humans and the environment,” the company claimed in a statement.

“InstaShield device is a Make in India product. Hitesh says that when the testing of this device was going on, by that time 8 variants of Corona had arrived. The device was tested for all variants and the results were positive. This device is capable of killing the virus in nanoseconds. Within a month of its launch, this device was sold for Rs.1.25 crore. By November 2022, the sales figure had reached Rs 10 crore. In the current financial year, the profit is expected to be Rs.5-6 crore and the sales will be Rs.14-15 crore. The InstaShield device can be ordered online from the company’s website and Amazon. Apart from this, dealers and distributors have been made all over India. The company has appointed Shruti Haasan as its brand ambassador,” the statement added.

After Hyderabad, the company is now considering setting up its manufacturing unit in UP.

“During the meeting with the UP delegation on Wednesday, both the promoters signed an MoU for an initial investment of 20 crores in UP. Apart from setting up the unit in UP, the company will also do its marketing and promotion here. Hitesh said that UP is a big market and he is impressed by the major changes in infrastructure, connectivity and law and order here under the leadership of CM Yogi. He sought support from the representatives of the government for their investments as well as large-scale business in UP. On behalf of the representatives, they were informed about the safe environment and all the reliefs and incentives provided by the government to investors,” the release said.

“The company is working on enhancing the InstaShield device, after which one device will be sufficient to kill the virus in an area of 25,000 square feet. Work is on to make it effective for swine flu and bird flu as well. InstaShield is set to launch its IPO in December 2023. Exports are expected to start by February 2023. Through investment in UP, the company will be able to use a bigger platform and will be able to earn huge profits under the umbrella of CM Yogi,” Hitesh, a company official said.

Read also: India targeting global arena with high value pharma med-tech products, says Mansukh Mandaviya
InstaShieldCOVID 9coronavirus
Source : ANI
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    ABYSS Trial Finds Elevated BP, HR & Deleterious CV Outcomes After Beta blocker Withdrawal Post-MI: EuroPCR 2025 Update

    ABYSS Trial Finds Elevated BP, HR & Deleterious CV Outcomes After Beta blocker Withdrawal Post-MI:...

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    View All

    Journal Club Today

    AI vs. Clinicians: Study Explores the Future of Diagnosing in Healthcare

    AI vs. Clinicians: Study Explores the Future of Diagnosing in Healthcare

    View All

    Health News Today

    Health Bulletin 05/June/2025

    Health Bulletin 05/June/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok